The 2026 list of medical technologies approved for innovation funding (NUB) released in Germany

On January 30, 2026, the Institute for the Hospital Remuneration System (InEK) published the list of innovation funding (NUB) requests submitted by hospitals in 2025. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained a positive status 1.

Of the 1,084 submitted technologies, 326 (30%) received status 1, indicating that the suggested procedure or medical device met the NUB criteria. Now, hospitals can negotiate innovation funding for these technologies with sickness funds.

Furthermore, 36 (3%) of the technologies received differentiated status, meaning that status 1 is granted only under certain conditions.

Below are some examples of medical technologies that obtained status 1. The technologies with differentiated status were not included in the list.

• Covered endoprostheses with bioactive surface for dialysis shunt revision;
• Endoscopic sleeve gastrectomy (endoscopic sleeve gastroplasty);
• Endoscopic thermal ablation of the duodenal mucosa to reduce insulin resistance;
• Endovascular implantation of an extracorporeal centrifugal pump for circulatory support;
• Endovascular implantation of a tricuspid valve replacement;
• Hemodynamically effective implant for the endovascular treatment of intracranial aneurysms and brain-supplying cervical vessels;
• Implant for direct acoustic stimulation of the cochlea (DACI);
• Implantation of a gastric pacemaker;
• Insertion of a bypass system to protect colorectal anastomoses;
• Joint transplants using thin-layered, fresh, living, allogeneic cartilage or bone material;
• Personalized external aortic root support (PEARS);
• Polymorphic, ultra-soft coils for intracranial embolization and aneurysm therapy;
• Selective CRP apheresis;
• Transapical mitral valve reconstruction by implantation of neochordae (PTFE);
• Transcatheter implantation of an interatrial shunt device for the treatment of heart failure;
• Thrombectomy of pulmonary vessels using a disc retriever system;
• Uterine transplantation;
• Vertebral body growth modulation technique;
• Wireless left ventricular stimulation system for cardiac resynchronization therapy.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.